生物相似药受到越来越多的关注Biosimilars – inflated expectations?In October 2006, Senators Waxman, Schumer and Clinton introduced the “Access to Life-SavingMedicines Act” to the US Congress in an attempt to establis...
生物相似性藥品Biosimilars 林治華1, 2 李元鳳3 王蓉君2 前言 生物相似性藥品(Similar Biological Medicinal Product, SBMP; informally “Biosimilar”)係指以生物技術衍生之生物藥品,於品質、安全及療效...
‘Biosimilar’ drugs poised to penetrate marketDraft regulations will pave the way for copycat antibodies and other large molecules.WBY HEIDI LEDFORDtesting, biosimilars could falter. For exam-zODNhen i...
-Introduction of biosimilar China development strategy APTSU/RA joint meeting dated on Sept 5th Jian Peng Oct. 2013Biosimilar Development Recommendation in China|
European Medicines Agency Evaluation of Medicines for Human UseCHMP/437/04 London, 30 October 2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)GUIDELINE ON SIMILAR BIOLOGICAL MEDICINAL PRODU...
卢氏至复公家谱一九九六年仲春月- 1 -
理论实习一体化教案
空间模版拼排
11 90 、高压电容器断电后自身仍带有电荷,若需再次合闸,应在其断电(3分钟)后进行。 91 、高压电容器的熔断器突然熔断时,(在查明原因之前,不可更换熔断器) 。 92 、高压电容器组的投入,退出与系统功率因数有关,一般的,当系统功率因数低于(0.85)时应投入高压电容器组。 93 、当电容器组发生(内部有异常声响)的异常现象时,应立即退出运行。 ...